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The contribution of inflammation to the progression of neurodegenerative diseases such asAlzheimer’s, Parkinson’s, and prion diseases
is poorly understood. Brain inflammation in animalmodels of these diseases is dominated by chronicmicroglial activationwithminimal
proinflammatory cytokine expression.However, these inflammatory cells are “primed” to produce exaggerated inflammatory responses
to subsequent lipopolysaccharide (LPS) challenges.We show that, using theME7model of priondisease, intracerebral challengewithLPS
results in dramatic interleukin-1 (IL-1) expression, neutrophil infiltration, and inducible nitric oxide synthase expression in the brain
parenchyma of prion-diseased mice compared with the same challenge in normal mice. Systemic inflammation evoked by LPS also
produced greater increases in proinflammatory cytokines, pentraxin 3, and inducible nitric oxide synthase transcription in prion-
diseased mice than in control mice and induced microglial expression of IL-1. These systemic challenges also increased neuronal
apoptosis in the brains of ME7 animals. Thus, both central and peripheral inflammation can exacerbate local brain inflammation and
neuronal death. The finding that a single acute systemic inflammatory event can induce neuronal death in the CNS has implications for
therapy in neurodegenerative diseases.
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Introduction
There is much speculation on the role of CNS inflammation in
the progression of neurodegenerative diseases such as Alzhei-
mer’s disease (AD) (Akiyama et al., 2000;Mrak andGriffin, 2001;
McGeer andMcGeer, 2003). The animalmodels available for AD
do not show significant neurodegeneration (Irizarry et al., 1997)
and, hence, although they show some evidence of inflammation,
they do not exhibit an inflammatory response that can be a re-
sponse to neurodegeneration. The prion diseases (transmissible
spongiform encephalopathies) share many pathological features
with AD and other chronic neurodegenerative conditions in that
they are typified by the extracellular deposition of insoluble
plaques, show neurodegeneration along neuroanatomical path-
ways, and display marked astrocytosis and microglial activation
(DeArmond, 1993; Price et al., 1993; Soto et al., 2003). We have
shown that during ME7-induced prion disease, there is an atyp-
ical CNS inflammatory response (Perry et al., 2002) dominated
by increases in TGF1 with very little contribution from the
proinflammatory cytokines interleukin-1 (IL-1), tumor ne-
crosis factor- (TNF-), and interleukin-6 (IL-6) (Betmouni et
al., 1996; Walsh et al., 2001; Cunningham et al., 2002). Similarly,
low expression of these cytokines has been reported in animal
models of AD and Parkinson’s disease (Sly et al., 2001; Depino et
al., 2003).
However, it is also known that peripheral infection can initiate
the synthesis of cytokines within the CNS (Laye et al., 1994;
Pitossi et al., 1997). We have shown recently that systemic chal-
lenge with bacterial endotoxin [lipopolysaccharide (LPS)] pro-
vokes exaggerated CNS IL-1 synthesis and sickness behavior
responses in animals with ongoing chronic inflammation (Com-
brinck et al., 2002), and this also appears to be true in transgenic
models of AD (Sly et al., 2001; Lee et al., 2002). In a previous
study, we proposed thatmicroglia in the prion-diseased brain are
in a “primed” state, and subsequent challenges, either centrally or
systemically, result in an amplified cytokine and inflammatory
response. This acutely exacerbated local inflammation may lead
to increased neuronal loss and functional deficit (Perry et al.,
2003).
In the current study, we used LPS to mimic aspects of central
or systemic infection and theME7model ofmurine prion disease
to model chronic neurodegeneration to address the hypothesis
that microglial cells, activated by chronic neurodegeneration, are
primed to produce greater proinflammatory responses to subse-
quent central and systemic inflammatory challenges. To achieve
this, we assessed proinflammatory cytokine expression, inflam-
matory cell infiltration, and expression of effector enzymes such
as cyclooxygenase 2 (COX-2) and inducible nitric oxide (NO)
synthase (iNOS) after intracerebral and intraperitoneal LPS chal-
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lenges. In addition, using immunohistochemical staining and
quantification of terminal deoxynucleotidyl transferase-
mediated biotinylated UTP nick end labeling (TUNEL)-positive
and activated caspase-3-positive cell death after intraperitoneal
LPS challenges, we addressed the hypothesis that this exaggerated
inflammation exacerbates the neurodegenerative process.
Together, these proposals comprise the “microglial priming
hypothesis,” which predicts that microglia, primed by an existing
pathology such as synapse, axon, or neuronal cell body degener-
ation or by amyloid deposition can be stimulated to an aggressive
state of inflammation by secondary influences, such as infection
and injury, and during this window of activation can exacerbate
neuronal death.
Materials andMethods
Animals and stereotaxic surgery. Female C57BL/6 mice were ob-
tained fromHarlan (Bicester, UK), housed in groups of five or six
under standard light and temperature regimes, and fed pelleted
food and water ad libitum. The mice were anesthetized intraperi-
toneally with Avertin (2,2,2-tribromoethanol) and positioned in
a stereotaxic frame. Two small holes were drilled in the skull, on
either side of themidline, to allow the bilateral injection of 1l of
a 10% w/v ME7-infected C57BL/6 brain homogenate made in
PBS. These injections were made directly into the dorsal hip-
pocampus (coordinates from bregma: anteroposterior, 2.0
mm; lateral,1.6 mm; depth,1.5 mm) using a 10l Hamilton
syringe with a 26 gauge needle. Control animals were injected
with a 10%w/v normal brain homogenate (NBH) in PBS, derived
from a naive C57BL/6 mouse. All procedures were performed in
accordance with a United Kingdom Home Office license.
Peripheral and central LPS challenges.ME7 prion-diseased an-
imals (which will be referred to asME7 animals throughout) and
NBH-injected animals (referred to as NBH throughout) were
subjected to acute intracerebral or intraperitoneal inflammatory
challenges (referred to as ME7LPS, ME7saline, NBHLPS,
intracerebrally or intraperitoneally, where appropriate). Nine-
teen weeks after ME7 or NBH injection, just before overt clinical
signs (Betmouni et al., 1999), a group of animals was injected
intrahippocampally with 2 g of LPS (NBH and ME7) or with
sterile saline (ME7) under avertin anesthesia as described previ-
ously and returned to their home cages once they had recovered
their righting reflex. An additional group of mice was injected
intraperitoneally with 500g/kg LPS (Salmonella equine abortus;
Sigma, Poole, UK) in sterile saline or with saline alone and re-
turned to their cages. The choice of 19 weeks post-ME7 inocula-
tion for all LPS or saline challenges was made based on our pre-
vious knowledge of the degree and regional distribution of
microglial activation in the animals at this time in disease and on
our previous studies showing exaggerated sickness behavior re-
sponses and hippocampal IL-1 expression in animals at this
stage in prion disease (Combrinck et al., 2002). The intracerebral
LPS dose used in these studies was based on its ability to induce
robust microglial IL-1 expression in normal animals and, for
the systemic challenges, was based on the dose required to pro-
duce a robust febrile response (Combrinck et al., 2002).
Tissue preparation. Animals challenged intracerebrally with
LPS were terminally anesthetized at 18 h after LPS and examined
for evidence of cell infiltration/inflammatory activation. LPS-
and saline-injected animals used for RNA extraction were termi-
nally anesthetized 6 h after intraperitoneal injection, transcardi-
ally perfused with heparinized saline, and the brains were
removed (n  5 for each animal group). Thick coronal sections
(2 mm) were taken at approximately 1.0 to 3.0 mm from
bregma, and the hippocampus and thalamus were quickly re-
moved, immediately frozen in liquid nitrogen, and stored at
80°C. Additional groups of intraperitoneally challenged ani-
mals were terminally anesthetized at 18 h after injection with LPS
or saline and transcardially perfused and fixed in 10% formalin
solution to investigate neutrophil infiltration, apoptotic cell
death and other aspects of the pathology (n  9 for ME7LPS
intraperitoneally; n 5 for ME7saline intraperitoneally; n 3
forME7; n 3 for NBH; n 5 for NBHLPS intraperitoneally).
Additional ME7 and NBH animals were challenged intraperito-
neally with LPS or saline and perfused with heparinized saline
and 10% formalin at 6, 9, and 13 h after systemic challenge to
examine the time course of caspase-positive cell death. At least
three animals were used at each time point for these studies.
Immunocytochemistry. Ten percent formalin-fixed tissue was
postfixed over 2 d in the same fixative and then paraffin embed-
ded. Sections (10m)were cut on amicrotome and floated onto
electrostatically charged slides. Immunocytochemistry was per-
formed for neutrophils (rabbit polyclonal anti-neutrophil serum,
MBS1, generated in-house), apoptotic cells [TUNEL (“Dead
End” staining kit; Promega, Southampton, UK) and cleaved
caspase-3 (Chemicon, Southampton, UK)], IL-1 (Peprotech,
London, UK), iNOS (BD Biosciences, Oxford, UK), glial fibril-
lary acidic protein (GFAP; Dako, High Wycombe, UK), COX-2
(Santa Cruz Biotechnology, Santa Cruz, CA), neurons [neuron-
specific nuclear protein (NeuN) (Chemicon) and neurofilament
heavy chain (NFH; Abcam, Cambridge, UK)], andmicroglia (to-
mato lectin; Sigma). All biotinylated secondary antibodies were
supplied by Vector Laboratories (Peterborough, UK), and all
staining was visualized using the ABC method using peroxidase
as enzyme, 0.015% v/v hydrogen peroxide as substrate, and dia-
minobenzidine as chromagen.
Tissues were dewaxed and rehydrated through xylene and al-
cohols. Endogenous peroxidase was eliminated by incubating
sections in 1% H2O2/methanol for 10 min.
Neutrophils. Sections for MBS-1 staining were treated with
pepsin 0.04% in 0.1MHCl for 20min at room temperature before
PBS washing, blocked in 10% normal goat serum, and incubated
with the primary antibody (Ab) at 1:200 for 2 h at room temper-
ature. After additional washing, the sections were incubated with
biotinylated goat anti-rabbit IgG and continued as described
above.
TUNEL. Sections for TUNEL staining were washed in 0.85%
NaCl and then PBS, pretreatedwith proteinase K (20g/ml), and
permeabilized using 0.1% Triton X-100 for 10 min at room tem-
perature. Sections were preincubated with equilibration buffer
for 10 min and then with incubation medium for 2 h at 37°C,
labeling apoptotic cells with fluorescein. The reaction was
stopped using a sodium citrate solution. Sections were blocked
with 10% normal goat serum and incubated with biotinylated
goat anti-fluorescein antibody before continuing as described
above. TUNEL-positive cells were counted in full coronal sec-
tions and included only if displaying shrunken morphology and
condensed chromatin as well as being TUNEL labeled.
IL-1. Sections for IL-1were incubated in citrate buffer, pH
6, and microwaved two times for 3 min with 5 min cooling be-
tween incubations. They were washed in TBS and blocked with
50% normal goat serum before overnight incubation at 4°C with
the primary antibody at 1:50, prepared in 50% serum to block
nonspecific interactions with activated astrocytes. The sections
were washed and then incubated with biotinylated goat anti-
rabbit antibody and continued as described above.
Microglia. Sections for tomato lectin staining were washed
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three times in TBS 1% Triton X-100 containing 1 mM magne-
sium, manganese, and calcium chlorides. Biotinylated tomato
lectin was prepared at 50 g/ml in the same buffer, and sections
were incubated overnight at 4°C. After thorough washing, the
protocol continued as described above.
COX-2. Sections for cyclooxygenase-2 staining were
quenched with 1% H2O2 in absolute methanol for 20 min and
washed briefly in PBS before antigen retrieval by microwaving in
citrate buffer two times for 3 min with 5 min cooling between
incubations. After washing and blocking with 10% horse serum
in PBS for 2 h, the primary Ab (goat polyclonal anti-Cox-2 anti-
body; Santa Cruz Biotechnology) was diluted 1:1000 in PBS and
incubated overnight at room temperature. The sections were
thenwashed in PBS, incubatedwith biotinylated affinity-purified
horse anti-goat IgG andprocessed forABCperoxidase reaction as
above.
iNOS. Sections were quenched, pretreated with citrate buffer
and microwaving, and digested with 0.04% pepsin as outlined
above and then washed in PBS before blocking in 10% normal
goat serum and incubation overnight at 4°Cwith a 1:100 dilution
of a rabbit polyclonal antibody against iNOS. After additional
washing with PBS, the sections were incubated with a goat anti-
rabbit secondary antibody, and the ABC andDAB reactions were
completed as above.
NeuN. NeuN staining was achieved using the same citrate
buffer pretreatment as above, followed by 30min in normal horse
serum (10%), overnight incubation with the primary antibody at
1:5000, incubation with a horse anti-mouse secondary at 1:100
for 40 min, and completion of the ABC and DAB reactions as
above.
Cleaved caspase-3.Activated caspase-3 was examined to deter-
mine the mechanism of cell death and also to facilitate double-
labeling of dying cells by examining cells earlier in the cell death
cascade. After citrate buffer and micro-
wave pretreatment, sections were incu-
bated with pepsin 0.04% in 0.1 M HCl for
20 min at room temperature and then
washed before application of 10% normal
goat serum for 30 min followed by over-
night incubation at room temperature
with the primary antibody at a dilution of
1:50. Goat anti-rabbit secondary antibody
was applied for 40 min at room tempera-
ture, and the reaction was completed as
above.
Double staining of NFH with caspase-3.
To facilitate double staining of NFH and
cleaved caspase-3, it was necessary to pre-
label the rabbit anti-NFH antibody to
avoid cross-reactivity between successive
goat anti-rabbit secondary antibodies.
Thus, anti-cleaved caspase-3 staining was
performed first, as above with the substi-
tution of an Alexa Fluor 488-linked goat
anti-rabbit secondary antibody for the bi-
otinylated one used above. Sections were
then incubated with an NFH antibody
prelabeled with a Zenon Alexa Fluor 546
kit (Invitrogen, Paisley, UK). The labeling
simply attaches the fluorchrome directly
to the primary antibody, obviating the
need for a secondary antibody. This label-
ing was performed according to the in-
structions of the manufacturer, using a label to antibody ratio of
4:1 and a final antibody dilution of 1:250. This ratio and antibody
concentration had been observed previously to give good-quality
NFH staining in a single labeling experiment. For the purposes of
nuclear counterstaining, we used TOPRO-3 to give fluorescence
at 633 nm.
Confocal imaging.Triple-stained slides were imaged on a Leica
(Nussloch, Germany) SP2 confocal laser-scanning microscope,
using simultaneous excitation at 488, 546, and 633 nm.AZ-series
was obtained through the thickness of the tissue (10 m) from
which representative 1 m optical sections were extracted. Fluo-
rochromes were also excited sequentially rather than simulta-
neously to exclude the possibility of “bleed through” from fluo-
rochromes with overlapping spectra.
RNA extraction. Total RNA was extracted from brain samples
using Qiagen (Crawley, UK) RNeasy mini columns according to
the instructions of the manufacturer. Contaminating genomic
DNA was degraded during extraction with Qiagen DNase1 en-
zyme. The typical yield for brain tissue was5g per extraction.
RNA was stored at80°C until cDNA synthesis and PCR assay.
Taqman reverse transcription-PCR assay. All equipment and
reagents were supplied by Applied Biosystems (Warrington, UK)
unless otherwise stated. Assays for serum amyloid A (SAA), 2
antiplasmin (2-AP), and complement 3 (C3) were performed as
described previously (Wilcockson et al., 2002). Assays for pen-
traxin 3 (PTX3), IL-1, IL-6, and TNF were designed using the
published sequences for these genes, applied to Primer Express
software. Where possible, probes were designed to cross an in-
tron such that they were cDNA specific. Table 1 lists the se-
quences for primers and probes for each assay. All primer pairs
were checked for specificity by standard reverse transcription
(RT)-PCR using Promega PCR reagents followed by gel electro-
Table 1. Mouse cytokine and acute phase protein Taqman primer and probe sequences
Target Accession number Oligonucleotide Sequence Amplicon size (bp)
SAA M13522 Forward primer 5-GCCATGGAGGGTTTTTTTCATT-3 80
Reverse primer 5-CCTTTGGGCAGCATCATAGTTC-3
Probe 5-CACATGTCTCCAGCCCCTTGGAAAGC-3
2-AP Y12312 Forward primer 5-GCGGTTCACAGTGTCGGT-3 66
Reverse primer 5-TCCAGCAGGAACCATCGAA-3
Probe 5-ACATGATGCACGCGGTGTCATATCCT-3
C3 J00367 Forward primer 5-CCATGTATTCCATCATTACTCCCAA-3 72
Reverse primer 5-CGTGGGCCTCCAGTCAGA-3
Probe 5-CCTACGGCTGGAGAGCGAAGAGACC-3
PTX3 X83601 Forward primer 5-ACAACGAAATAGACAATGGACTTCAT-3 62
Reverse primer 5-CTGGCGGCAGTCGCA-3
Probe 5-CCACCGAGGACCCCACGCC-3
IL-1 M15131 Forward primer 5-GCCACCCACCCTGCA-3 69
Reverse primer 5-ACCGCTTTTCCATCTTCTTCTT-3
Probe 5-TGGAGAGTCTGGATCCCAAGCAATACCC-3
TNF M11731 Forward primer 5-CTCCAGGCGGTGCCTATG-3 149
Reverse primer 5-GGGCCATAGAACTGATGAGAGG-3
Probe 5-TCAGCCTCTTCTCATTCCTGCTTGTGG-3
IL-6 NM_031168 Forward primer 5-TCCAGAAACCGCTATGAAGTTC-3 72
Reverse primer 5-CACCAGCATCAGTCCCAAGA-3
Probe 5-CTCTGCAAGAGACTTCCATCCAGTTGCC-3
TGF1 AJ009862 Forward primer 5-CGTGGAAATCAACGGGATCA-3 84
Reverse primer 5-GGCCATGAGGAGCAGGAA-3
Probe 5-ACCTGGGCACCATCCATGACATGA-3
iNOS NM_010927 Forward primer 5-CAGCTGGGCTGTACAAACCTT-3 95
Reverse primer 5-CATTGGAAGTGAAGCGTTTCG-3
Probe 5-CGGGCAGCCTGTGAGACCTTTGA-3
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phoresis. Each primer pair produced a dis-
crete band of the expected amplicon size
(data not shown).
For Taqman PCR, cDNA was gener-
ated from total RNA using Taqman Gold
RT reagents. Two hundred nanograms of
total RNA were reverse transcribed in a 10
l reaction volume. One microliter of the
RT reaction (equivalent to 20 ng of RNA)
was subsequently used for the PCR, per-
formed as described previously (Wilcock-
son et al., 2002). The housekeeping gene
glyceraldehyde-3-phosphate dehydroge-
nase (GAPDH) was measured in each
sample using Applied Biosystems Rodent
GAPDH Taqman kit.
For the acute-phase reactants SAA, 2-
AP, C3, and PTX3 assays, standard curves
weremade from in vitro transcripts of each
gene as described previously (Wilcockson
et al., 2002). Acute-phase protein mRNA
levels were thus expressed as copies per
nanogram of total RNA (as determined by
normalization with GAPDH). Cytokine
mRNA expression in prion-diseased and
normal animals was assessed by relative
quantitation as described previously
(Cunningham et al., 2005). A standard
curve was constructed from total RNA iso-
lated from mouse brain tissue after intra-
cerebral challenge with 2.5 g of LPS,
which is known to upregulate all target
transcripts of interest in this study. This
standard curve was constructed using a
higher concentration of RNA in the
reverse-transcriptase reaction than for
samples for analysis to ensure that the cy-
tokine transcription of all animal groups
will fall within the range of the standard
curve constructed. Serial one in five dilu-
tions of the cDNA synthesized from brains
of LPS-injected mice were made and a
curve plotted of the Ct value (the cycle
number at which the transcribed gene
crosses the threshold of detection) versus
the log of the concentration (assigned an arbitrary value, because
the absolute concentration of cytokine transcripts is not known).
Thus, the standard curve generates arbitrary values for concen-
tration. These data were then normalized for GAPDH concentra-
tion in each sample.
Statistics. Animal groups in the peripheral LPS challenge
groups were compared by ANOVA, and data were treated as
significant at the 95% confidence interval. Cell numbers after
TUNEL and caspase-3 stains were compared by ANOVA with
Bonferroni’s post hoc test.
Results
Microglial activation after intracerebral LPS
Wepreviously used CD68 andmajor histocompatibility complex
class I and II to demonstrate that microglial cells show activation
in prion disease, as defined by altered morphology and upregu-
lation of cell surface markers (Betmouni et al., 1996). Here, we
used tomato lectin immunohistochemistry and found that this
marker also reveals microglial cells with altered morphology in
the disease (Fig. 1b). In addition, all features appropriate to prion
disease pathology at 19 weeks after inoculation were evident in
the tissue [vacuolation and CA1 neuronal loss (Fig. 1b,c) and
PrPSc deposition (data not shown)]. Tomato lectin also labels the
vasculature.NBHLPS intracerebral animals show clear staining
of the vasculature and a small number of microglial cells with
thin, relatively ramified processes (Fig. 1a). The staining in the
case of ME7 animals injected intracerebrally with saline shows
many microglial cells that are more densely stained with a less
ramified and characteristic activated morphology (Fig. 1b). ME7
animals injected intracerebrally with LPS also show clear activa-
tion by these criteria, but the morphological appearance is not
significantly different to those not injected with LPS (Fig. 1b,c).
Thus, at a morphological level, we observed no clear difference
between microglia in ME7 animals with or without a subsequent
LPS challenge.
Figure1. Neuropathological and inflammatory changesafter intracerebral LPS.a– c, Tomato lectin staining formicroglial cells
in brains from NBHLPS (a), ME7saline (b), and ME7LPS (c) animals. d–f, IL-1 immunostaining in NBHLPS (d),
ME7saline (e), and ME7LPS (f ) brains. MBS-1 immunostaining for infiltrating neutrophils in NBHLPS (g, j), ME7saline
(h, k), and ME7LPS (i, l ) brains is shown at 10 (g, h, i) and 40 (j, k, l ), respectively. m–o, Immunostaining for iNOS in
NBHLPS (m), ME7saline (n), and ME7LPS (o) brains. Scale bar: (in a) a–f, j– o, 100m; (in g) g, h, i, 500m.
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IL-1 expression after LPS challenge
Immunohistochemical staining after intracerebral LPS challenge
in NBH animals showed some staining for IL-1. This staining
was clearly localized to activated microglia both in the vicinity of
the intracerebral LPS injection and also the overlying ipsilateral
cortex and underlying dorsal thalamus (Fig. 1d). Infiltrating neu-
trophils (see below) also showed some IL-1 expression. ME7
animals injectedwith saline did not show any IL-1 staining (Fig.
1e), as we described previously for ME7-infected mice (Walsh et
al., 2001). LPS-injected ME7 animals showed a greatly increased
density of IL-1 staining, both in the number of positively
stained cells and in the intensity of staining in each activated cell
(Fig. 1f). IL-1 staining was observed in the injected hippocam-
pus but showed a wider distribution in adjacent cortex and thal-
amus and in the contralateral hippocampus. Thus, at a functional
level, the microglial cells from ME7 animals injected with saline
or LPS are markedly different despite showing the same
morphology.
Intracerebral challenge with LPS, neutrophil infiltration
Intracerebral challenge with 2 g of LPS provoked some neutro-
phil infiltration into the parenchyma of NBH animals (Fig. 1g,j).
This infiltration was relatively dispersed, and the extent of infil-
tration was limited, although there was evidence of neutrophil
adherence to the vasculature. There was no infiltration in ME7
animals challenged with saline (Fig. 1h,k). LPS challenge ofME7-
infected animals produced massive neutrophil infiltration, and
this influxwas centered on the site of intracerebral challenge (Fig.
1i,l). Blood vessels and pial membrane-bound spaces were filled
with neutrophils in addition to the very considerable numbers in
the parenchyma. There was also some evidence for hemorrhage,
whichwas not evident inNBHanimals challenged intracerebrally
with this dose of LPS.
iNOS staining after intracerebral challenge
We have shown previously that iNOS is not expressed in the
brains of ME7-infected animals (Walsh et al., 2001). There was
no detectable expression of iNOS in the brains of ME7 animals
injected intracerebrally with saline (Fig. 1m) or in NBHLPS
intracerebral animals (Fig. 1n). In contrast, intracerebral LPS
challenge to ME7 animals induced clear expression of iNOS in
microglial cells and in some infiltrating neutrophils (Fig. 1o).
CNS cytokine and acute-phase responses to
peripheral inflammation
To investigate whether ME7 animals showed exaggerated brain
cytokine and acute-phase reactant mRNA levels after peripheral
inflammation, we injected ME7 and NBH-injected mice intra-
peritoneallywith LPS or saline andmeasured cytokine transcripts
after 6 h.
Cytokine expression in LPS-injected NBH andME7 mice
ME7 animals challenged with LPS intraperitoneally showed
greater increases in IL-1 than NBH animals given the same LPS
challenge (Fig. 2a) ( p  0.001). ME7 mice show slightly higher
IL-1 transcript levels than NBH mice, but this cannot account
for the difference between the LPS challenges; the level of expres-
sion of IL-1mRNA in the ME7LPS group was more than the
sum of NBHLPS and ME7 alone. The IL-1 increase, induced
by LPS inME7 animals, was approximately threefold greater than
that induced by LPS in NBH animals.
The pattern of TNF expression was similar to that of IL-1
expression in the same experiment (Fig. 2b). ME7 mice showed
increased levels of TNF transcripts compared with NBH mice.
TNF expression in theME7LPS groupwas greater than that in
the NBHLPS group ( p 0.01). Once again, this difference was
not accounted for by the baseline expression observed in ME7-
infected mice (i.e., the effect was more than additive). The in-
crease inTNF induced by LPS inME7 animals is 1.7-fold greater
than that induced by LPS in NBH animals.
IL-6 transcripts were below the assay limit in both the NBH
andME7 groups. Peripheral challenge with LPS induced quanti-
fiable levels of IL-6 in the brains of both NBH and ME7-infected
mice (Fig. 2c). The IL-6 increase induced by LPS inME7 animals
is approximately threefold greater than that induced by LPS in
NBH animals ( p  0.01). This pattern was not observed for
TGF1, which is clearly elevated in ME7, ME7saline and
ME7LPS but not significantly different between these groups.
Intraperitoneal LPS does not induce TGF1 in the hippocampus
of either ME7 or NBH animals (Fig. 2d). Transcription of the
gene for iNOS is consistent and low among NBH, ME7,
NBHLPS, andME7saline groups and shows elevation only in
the ME7LPS intraperitoneally challenged group ( p  0.01)
(Fig. 2e).
Acute-phase reactant expression in NBH andME7mice
challenged intraperitoneally with LPS
A peripheral challenge with LPS produced increases in acute-
phase reactantmRNA expression in the brains of NBH andME7-
infected mice. In the ME7saline and NBHLPS intraperito-
neal groups, there was no difference in the level of PTX3 mRNA
(Fig. 3a). However, when the ME7 group was challenged with
LPS, there was a dramatic increase in PTX3 gene expression,
more than could be accounted for by the ME7 and LPS treat-
ments alone. The difference between ME7-infected and
ME7LPS intraperitoneally was statistically significant ( p 
0.001), as was the difference between ME7LPS intraperitone-
ally and NBHLPS intraperitoneally ( p  0.01). There was no
statistical difference in 2-AP mRNA between the ME7saline
intraperitoneal, ME7LPS intraperitoneal, and NBHLPS in-
traperitoneal groups (Fig. 3b), although there was a trend toward
increased 2-AP expression in the two LPS-injected groups.
There were also no statistical differences in C3mRNA expression
in any of the treatments (Fig. 3c), although ME7LPS intraperi-
toneal animals showed a trend toward increased expression com-
pared with the ME7saline intraperitoneal and NBHLPS in-
traperitoneal groups. SAA mRNA expression in ME7LPS
intraperitoneal and NBHLPS intraperitoneal brains was mark-
edly elevated compared with ME7saline intraperitoneal ani-
mals (Fig. 3d) ( p  0.01), but there was no difference between
SAA expression in the two LPS-injected groups.
Microglial phenotype, transduction of peripheral
inflammatory signal
The morphological appearance of microglial cells in both ME7
and ME7LPS intraperitoneal groups is characteristic of acti-
vated cells compared with that in NBH animals challenged intra-
peritoneally with LPS (Fig. 4a,b). However, as was evident after
intracerebral LPS challenge, intraperitoneal LPS did not induce
any additionalmorphological change in thesemicroglia as judged
by tomato lectin staining (Fig. 4c). After LPS challenge intraperi-
toneally, perivascular macrophages and endothelial cells of the
hippocampal vasculature are shown to express IL-1 (Fig. 4d).
No positively stained microglia could be observed in this NBH
groupnor in theME7 group injectedwith saline (Fig. 4d,e).How-
ever, endothelial cells, perivascular macrophages, and microglial
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cells in the vicinity of the hippocampal vasculature showed clear
IL-1 staining after intraperitoneal LPS in ME7 animals (Fig. 4f,
inset). Thus, the activated microglia present in prion-diseased
brains are primed to produce a greater IL-1 response to the
peripheral LPS-induced inflammatory signal.
The endothelial expression of cyclooxygenase and consequent
secretion of prostaglandin E2 is believed to be one common
mechanism of the transduction of peripheral inflammatory sig-
nals across the blood–brain barrier (Ek et al., 2001).We observed
very marked upregulation of COX-2 on the endothelial cells and
perivascular macrophages (Fig. 4g,i). Prion disease per se does
induce microglial COX-2 expression (Fig. 4h), as described pre-
viously (Walsh et al., 2000).
Consequences of increased CNS inflammation after
peripheral LPS
To examine the consequences of increased brain inflammation
resulting from peripheral LPS challenge, we examined cell death.
We used TUNEL staining to label cells undergoing DNA frag-
mentation. This method may reveal cells that are positively
stained but that do not subsequently undergo cell death. For this
reason, we included in our counts only cells that stain positive
and show a shrunken morphology and clearly condensed chro-
matin in the nucleus, consistent with irreversible cell damage
(Fig. 4j, inset). There is considerable apoptotic cell death occur-
ring inME7 animals at 19 weeks after injection and indeed a very
low level in normal animals. As shown in Table 2, there were
Figure 2. The impact of systemic challenge with LPS on cytokine and inflammatory gene
transcription inME7andNBHmice. LPSproducedgreater IL-1 (a), TNF (b), IL-6 (c), and iNOS
Figure 3. Impact of systemic challenge with LPS on CNS acute phase reactant transcription
expression in ME7 and NBH animals. PTX3 (a), 2-AP (b), C3 (c), and SAA (d) mRNA were all
increasedbyperipheral LPS injection, but only PTX3 showeda statistically significant increase in
theME7LPS group relative to NBHLPS. All data are presented asmean SEM. *p 0.05;
**p 0.01; ***p 0.001; ANOVA. NBHLPS, n 4; ME7saline, ME7LPS, n 5. Sal,
Saline.
4
(e) mRNA increases in ME7 animals than in NBH animals. The difference between the IL-1,
TNF, IL-6, and iNOS expression inNBHLPS andME7LPSwas statistically significant ( p
0.001, p 0.01, and p 0.05, respectively). All ME7 groups were statistically significantly
different from both NBH groups in TGF1 transcription (d), but LPS (intraperitoneal) did not
produce increases in TGF1 in either NBH or ME7 animals. Black bars represent mean SEM.
*p 0.05; **p 0.01; ***p 0.001; ANOVA. NBHLPS, n 4; ME7saline, ME7LPS,
n 5. Sal, Saline.
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Figure 4. Neuropathological and inflammatory changes after intraperitoneal LPS. a– c, Tomato lectin staining formicroglial cells in brains fromNBHLPS (a), ME7saline (b), andME7LPS
(c) animals. d–f, IL-1 immunostaining in NBHLPS (d), ME7saline (e), and ME7LPS (f ) brains (inset illustrates clear IL-1-positive staining in cells with microglial morphology at 63
magnification). Immunostaining for cyclooxygenase-2 inNBHLPS (g),ME7saline (h), andME7LPS (i) brains is shownat40 (g,h, i) and63 (inset), respectively. j, TUNEL-positive staining
in three cells (arrows) in a single field in the thalamus of anME7LPS brain. Inset, Hoescht 33352-stained nucleus showing shrunken and condensed chromatin (left) comparedwith normal (right).
TUNEL-positive DAB staining in a CA3neuron is shown (k), as identified bymorphology and location,with failure to clearly double stain for NeuN (VIP chromagen). l,m, Activated caspase-3-positive
cells showing neuronal morphology. An activated caspase-3-positive neuron (o), double stained using immunolabeling for neurofilament heavy chain (p) with overlay (q) in a 1m section by
confocal microscopy is shown. n shows TOPRO-3 nuclear stain. Scale bars: (in a) a–i, 100m; (inm) l,m, 80m; n–q, 50m.
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increased numbers of TUNEL-positive
cells showing apoptotic morphology in
ME7 animals with respect to NBH ani-
mals. Systemic injection of saline had no
significant effect on the number of apo-
ptotic cells in ME7 animals at 19 weeks
after inoculation. Similarly, the intraperi-
toneal injection of LPS had no significant
effect on the numbers of apoptotic cells in
NBH animals. However, LPS challenge
produced a statistically significant in-
crease in the number of apoptotic cells in
ME7 animals (Fig. 4j; Table 2). When cor-
rected for baseline TUNEL-positive num-
bers (i.e., that in NBH animals), cell death in prion-diseased an-
imals is more than twice as high after LPS challenge than in
unchallenged or saline-challenged ME7 animals (Table 2). We
attempted to use double immunocytochemistry to identify these
dying cells as neuronal, but because of the advanced stage of
degeneration at 18 h, these cells could not be identified morpho-
logically and express no detectable cellular antigens such asGFAP
or NeuN (Fig. 4k). For this reason, we also stained sections from
these animals and others taken from animals 3, 6, 9, and 13 h after
LPS with anti-activated caspase-3 antibodies. This staining re-
vealed less dying cells than the TUNEL technique, consistent with
the shorter temporal window of expression of activated caspase-3
(Brecht et al., 2001). However, in these studies, ME7 animals
challenged with LPS intraperitoneally contained approximately
twice as many activated caspase-3-positive cells as ME7 animals
challenged with saline (Table 2). Many of the activated caspase-
3-positive cells had morphology or localization, suggesting that
they were neurons (Fig. 4l,m), but double staining of these cells
also presented some technical difficulties because of the altered
antigen expression of degenerating cells (i.e., these dying cells
were also negative for GFAP, NeuN, and tomato lectin). How-
ever, the vast majority of these cells stained positive for activated
caspase-3 and the neuronal marker neurofilament heavy chain
(Fig. 4o–q). This protein was selected on the basis of its biochem-
ical stability, whichwe judged likely to ensure its preservation late
into the process of cell degeneration.
Discussion
In the current study, we demonstrated that in prion disease-
induced chronic neurodegeneration,microglia show characteris-
tic alterations of morphology and antigen expression typical of
activated microglia but do not produce the inflammatory medi-
ators IL-1 or iNOS. However, these cells are primed to produce
a greater response to a subsequent inflammatory challenge,
whether administered intracerebrally or intraperitoneally. The
inflammatory response to intracerebral LPS inME7 animals with
previous microglial activation is severe, with marked microglial
IL-1 and iNOS expression and massive neutrophil infiltration.
Similarly, the intraperitoneal LPS challenge produced marked
microglial IL-1 expression and transcription of other inflam-
matory genes such as IL-6, TNF-, PTX3, and iNOS in prion-
diseased animals. Significantly, in animals with ongoing neuro-
degeneration and microglial activation, this single systemic LPS
challenge induced neuronal death.
Consequences of intracerebral LPS challenge
Labeling with tomato lectin clearly shows that prion disease in-
duces microglial activation on the basis of increased cell num-
bers, increased expression of lectin-targeted antigen, and mor-
phological features of activation. However, these cells do not
synthesize detectable amounts of IL-1 protein. After intracere-
bral stimulation with LPS, these microglial cells produce readily
detectable IL-1 in the absence of any additional change in mor-
phology or numbers. Thus,microglial morphology is insufficient
for analysis of the phenotype of these cells: activated microglial
cells can show clear divergence in function in vivo.
Intraparenchymal injection of LPS in the normal brain pro-
vokes limited neutrophil recruitment into the parenchyma
(Andersson et al., 1992). LPS challenge to the brain parenchyma
of ME7 animals provoked very marked neutrophil infiltration
not apparent in LPS-challenged NBH animals. Thus, the micro-
glial IL-1 synthesis has clear biological consequences. This neu-
trophil infiltration is probably induced via the expression of the
CXC chemokine macrophage inflammatory protein-2. This che-
mokine is induced by IL-1 (Xu et al., 1995), and neutrophil
infiltration to the CNS can be blocked by neutralization of either
IL-1 or the rat equivalent CXC chemokine, cytokine-induced
neutrophil chemoattractant 1 (Anthony et al., 1998). IL-1 ex-
pression is also known to induce iNOS (Serou et al., 1999) and
thus may underlie the microglial expression of iNOS seen here.
The production of the oxidant NO has been demonstrated pre-
viously to be involved in neuronal death and damage (Takeuchi
et al., 1998; Smith et al., 2001).
Intracerebral challenge with LPS in the current study demon-
strates the degree to which the brain microenvironment and its
cellular constituents are primed during chronic neurodegenera-
tion to produce exaggerated responses to subsequent inflamma-
tory challenges. Our data suggest that the inflammatory response
to insults such as CNS infection, stroke, and head injurywould be
exacerbated in those already experiencing neurodegeneration-
associated microglial activation. Given the evidence that IL-1
exacerbates ischemic neuronal injury (Stroemer and Rothwell,
1998), we predict that strokes and CNS infections should have
more severe consequences in persons with ongoing neurodegen-
eration. There are few studies on the impact of CNS infection on
dementia, but there are a number of studies showing that cerebral
ischemia has more severe consequences in patients with ongoing
dementia (Appelros et al., 2002; Koistinaho and Koistinaho,
2005). The results presented here provide a possible explanation
of these clinical findings.
CNS consequences of systemic inflammation
It is known that peripheral inflammation can stimulate central
inflammatory cytokine mRNA and protein synthesis (Laye et al.,
1994; Pitossi et al., 1997) and that these cytokines coordinate a
group of adaptive behavioral changes collectively known as sick-
ness behavior (Konsman et al., 2002). In prion-diseased mice, in
which there is prior microglial activation, LPS induces exagger-
ated sickness behavior and increased central synthesis of IL-1
Table 2. Numbers of apoptotic cellsa counted per coronal section at hippocampal level
Animal group TUNEL-positive cells Activated caspase-3-positive cells
NBH 5.3 0.2 (n 3) ND
ME7 26.8 1.6 (n 3) ND
NBHLPS 6.8 0.5 (n 5) 1.4 0.7 (n 5)
ME7LPS 50.2 2.3 (n9)b 12.2 2.0 (n5)b
ME7saline 27.8 3.0 (n 5) 6.6 1.3 (n 6)
Sectionswere taken between bregma2.0 and bregma2.5mm, and all apoptotic cells in coronal sectionswere counted by two blinded observers. Counts
in animals challenged intraperitoneally with saline or LPS were performed in brains perfused at 18 h after challenge. Apoptotic cells clearly identifiable as
ependymal/endothelial/vascular were omitted. Counts were averaged across four coronal sections per animal and averaged across at least five animals in all
key comparisons. Groups were compared statistically by ANOVA with Bonferroni’s post hoc test.
aAs identified by both positive staining and by cell and nuclear morphology.
bDenotes significant difference fromME7 alone or ME7saline, p 0.0167.
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(Combrinck et al., 2002). Using the same ME7 model, we now
show that LPS also induces exaggerated changes in a number of
cytokines and acute-phase reactants in degenerating brains.
Proinflammatory cytokine mRNAs for IL-1, IL-6, and TNF
were induced to higher levels by LPS in ME7 animals than in
NBH animals, and this could not be accounted for by the additive
effect of the individual treatments. This LPS challenge did not
result in acute elevation of TGF1, a gene already highly ex-
pressed in this model (Cunningham et al., 2002). This results in a
“switch” in the balance between proinflammatory and anti-
inflammatory cytokines andmay allow the activation of different
downstream cascades during the acute phase after systemic in-
flammation. These results are consistent with increased CNS cy-
tokinemRNAexpression after i.p. LPS in both amyloid precursor
protein overexpressing mice (Sly et al., 2001) and presenilin-1
mutant mice (Lee et al., 2002), indicating that this “microglial
priming” is not specific to murine prion disease.
Acute-phase reactant gene expression following LPS challenge
was generally similar in ME7 and NBH animals, but PTX3 was
highly induced by LPS in prion-diseased mice compared with
control animals. PTX3 is a member of the pentraxins, which are
thought to opsonize apoptotic cells, pathogens, and debris for
phagocytosis by Fc receptor-expressing cells (Bharadwaj et al.,
2001; Mold et al., 2002a,b). Like C-reactive protein, PTX3 has
been shown to exert control over the degree of activation of mac-
rophages: PTX3 overexpressing macrophages produce more ro-
bust responses to LPS challenges than controls (Dias et al., 2001).
The observed enhanced levels of PTX3 in the current study may
play a role in the exaggerated response to LPS.
If LPS does have effects on opsonization or phagocytosis, it is
possible that this systemic stimulation could also have some ben-
eficial roles in clearance of amyloid proteins as has been shown in
animal models of AD (DiCarlo et al., 2001; Herber et al., 2004).
However, a thorough discussion of this area is beyond the scope
of this study.
Thus, systemic inflammation in an animal with chronic neu-
rodegeneration induces an inflammatory phenotype that is dis-
tinct from that produced by either of these conditions alone but
which is also distinct from the additive effects of the individual
profiles. The peripheral cytokine responses are not different in
prion-diseased and normal animals (Cunningham et al., 2005),
and thus the exacerbation of the brain inflammatory response is
occurring at the CNS level. An increase in numbers and sensitiv-
ity of the microglial population is the most likely explanation for
this, but there are also more perivascular macrophages present at
the vasculature of prion-diseased animals than in normal animals
(Galea et al., 2005) and also activation of astrocytes in areas of
pathology, and these may also contribute to the enhanced CNS
response to the peripheral challenge.
Mechanisms and implications
We show that a single systemic LPS challenge of 500 g/kg is
sufficient to induce acute cell death in the brains of animals with
ongoing brain inflammation and that these dying cells are neu-
rons. It follows that serial acute inflammatory insults superim-
posed on ongoing chronic neurodegeneration may produce a
series of acute episodes of damage over the course of a chronic
neurodegenerative disease, and this may have a major impact on
the rate of degeneration. Repeated stimulations with LPS have
not been performed in these studies, because these animals are
known to become tolerant to LPS after repeated challenge (Greer
and Rietschel, 1978; Ziegler-Heitbrock, 1995). However, it has
been shown in the superoxide dismutase-1G37R model of amyo-
trophic lateral sclerosis that a relatively severe chronic stimula-
tion with LPS exacerbates neuronal death and motor neuron
axon degeneration (Nguyen et al., 2004). That a less severe in-
flammatory challenge is also sufficient to induce acute neuronal
death may have important consequences for patients with
chronic neurodegenerative disease subsequently exposed to com-
mon low-grade peripheral infections. Proinflammatory cyto-
kines, including IL-1 and TNF, are known to exacerbate neu-
ronal damage in acute injury models (Stroemer and Rothwell,
1998), and this may occur through IL-1-activated pathways
such as induction of inducible COX-2 (Serou et al., 1999), tissue
plasminogen activator (Eberhardt et al., 2002), iNOS (Tamatani
et al., 1998), and increased synthesis of the damaging reactive
oxygen species superoxide and peroxynitrite (Fink et al., 1999).
There is already clinical evidence that infections are deleteri-
ous in dementia. Delirium is a transient disorder of cognition and
attention and is a common consequence of systemic infection in
the elderly and demented (Elie et al., 1998). Episodes of delirium
significantly increase the risk of dementia (Rockwood et al.,
1999), shorten the time to permanent institutionalization (Pit-
kala et al., 2005), and are associated with long-term functional
decline (Murray et al., 1993) and increasedmortality (Rockwood
et al., 1999). There is also epidemiological and clinical evidence
that infections accelerate the progression of AD (Holmes et al.,
2003; Dunn et al., 2005). Together, these studies indicate that
insults that trigger delirium, such as infection, accelerate the neu-
rodegenerative process.
Conclusion
In closing, it seems important to reiterate that we currently have
little evidence that inflammation has a direct role in prion disease
progression per se: themicroglial response in prion disease and in
other animal models of neurodegeneration appears to be tightly
controlled to prevent exacerbation of the degenerative process.
But this inflammatory response alters the number, morphology,
and sensitivity of microglia such that the brain becomes primed
and more vulnerable to subsequent inflammatory insults (Sly et
al., 2001; Lee et al., 2002; Nguyen et al., 2004). These insults may
then impact on the rate of neurodegeneration. Suppression of
peripheral inflammation may be a relevant therapeutic target in
chronic neurodegeneration and may be a component of the pro-
tection of nonsteroidal anti-inflammatory drugs against the de-
velopment of AD.
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